Nanjing Chang'ao Pharmaceutical Co., Ltd.
+86-25-57759539 +86-
No. 2, Babai Road, Liuhe
Nanjing, Jiangsu,
China
21150-1500
Products & Services
-
- Sibutramine Hydrochloride Capsules
Web Result
- C Pharmaceutical Technology (Holdings) Limited
- AWARDS Details of the major awards and recognition that C & O Pharmaceutical Technology (Holdings) Limited has received for its new products and projects: Date Details of Award and Recognition Awarding Authority Dec 2009 Pantoprazole Sodium Enteric-Coated Capsules Jiangsu Department of Science and Technology Jan 2009 Research projects on PNA and 3 other potential Category One anti-infective dr...
- C Branded Products
- C&O Branded Products Product Packaging Trade Name Product Name Treatment Feiningda Ofloxacin Gel Treatment of skin soft tissues infections Antaen Capsules () Diclofenac Sodium Sustained Release Capsules *# Analgesic & Antipyretic Antaen Gel () Diclofenac Sodium Gel Analgesic & Antipyretic Aoweishu Vitamin U Aluminium Hydroxide and Magnesium Trisilicate Capsules # Treatment of excessive...
- Exclusive Products
- Exclusive Products Product Packaging Trade Name Product Name Treatment Amoxycillin Amoxycillin Capsules # Treatment of infections caused by bacteria sensitive to Amoxycillin Cefradine Cefradine Capsules # Treatment of infections caused by bacteria sensitive to Cefradine Ambroxol SR Ambroxol SR Capsules Treatment of acute and chronic respiratory disorders associated with viscid or excessive mucus F...
- C & O Pharmaceutical Technology (Holdings) Limited
- Back to Integrated Business ModelMANUFACTURING MANUFACTURING CAPABILITIES Located in Nanjing, Jiangsu Province, our manufacturing facilities occupy a site area of approximately 60,000 sq.m with a total gross floor area of over 20,000 sq.m. Our GMPcertified manufacturing facilities are equipped to handle 13 production processes to manufacture a wide array of C branded and CMO (contract manufacture)...
- Corporate Milestones
- CORPORATE MILESTONES Date Details December 2011 Delisted from Main Board of Singapore Exchange November 2011 Dispatch of notice of compulsory acquisition to acquire all the ordinary shares in the capital of C other than those shares already owned by the Offeror and its related parties October 2011 Close of mandatory unconditional cash offer with the Offeror and parties acting in concert owning an ...
Website Links:
Nanjing Chang'ao Pharmaceutical Co., Ltd. | 0.12 MB | Annual Reports | Business Development Contacts | C Branded Products | Corporate Milestones | Corporate Structure | Exclusive Products | Integrated Business Model | IR Contacts | Marketing & Distribution | Our Research Team | Prospects & Strategies | Video
Own this business?
Request to update the information